In today’s briefing:
- Hang Seng Index Rebalance – FOUR Names IN, None Out (The March to 80 Continues)
- Hang Seng Tech Rebalance – No Name Changes But Lots of Flow
- HSCEI Rebalance – One In, One Out, 3.1% One-Way Flow
- Hansoh Pharmaceutical (3692 HK): Strengthening Innovative Portfolio Through In-Licensing
- Wuxi Biologics (2269.HK) 2022H1 – Hard to Achieve V-Share Rebound
- ENN Energy (2688 HK): Seeing Sign of an Upturn
- China Internet Weekly (22Aug22): E-Commerce, Logistics, Online Game, Food Delivery
- Morning Views Asia: CIFI Holdings, Kawasan Industri Jababeka, Sino-Ocean Service, Times China
Hang Seng Index Rebalance – FOUR Names IN, None Out (The March to 80 Continues)
- The Hang Seng Index Team announced four changes to the Hang Seng Index, bringing membership to 73 from 69, on its way to 80, but later than originally targeter mid-2022.
- Additions are China Shenhua Energy Co H (1088 HK), Chow Tai Fook Jewellery (1929 HK), Hansoh Pharmaceutical (3692 HK), and Baidu (9888 HK).
- Official placeholder turnover is about 3.8%. Small changes due to capping updates still to come. China Shenhua and possibly Chow Tai Fook look interesting as trades.
Hang Seng Tech Rebalance – No Name Changes But Lots of Flow
- The Hang Seng Index Team announced the index review for the Hang Seng Tech Index Friday after the close. There were no additions or deletions.
- However, there is a 4.9% one-way turnover on reasonably heavy FAF and capping changes. Sensetime sees a huge FAF increase. Tencent, Meituan, and Kuaishou get re-capped higher. Xiaomi lower.
- There is a fair bit of flow, but the obvious big name – SenseTime Group (20 HK) – has potential overhang. Watch Haier Smart Home Co Ltd (6690 HK).
HSCEI Rebalance – One In, One Out, 3.1% One-Way Flow
- On Friday the Hang Seng announced the changes to the HSCEI for the September rebalance. SenseTime Group (20 HK) is an ADD. China Pacific Insurance (2601 HK) a DELETE.
- Meituan (3690 HK) and Tencent (700 HK) see their weights re-capped upwards. Alibaba Group (9988 HK) capped slightly lower. There are a number of FAF changes.
- Little stands out other than the China Pacific Insurance (2601 HK) deletion. It runs low volatility vs Peers so could be a good buy on dip.
Hansoh Pharmaceutical (3692 HK): Strengthening Innovative Portfolio Through In-Licensing
- Hansoh Pharmaceutical (3692 HK) is strengthening its innovative drug pipeline. In August the company in-licensed one clinical stage drug candidate for women health, having large addressable market opportunity in China.
- Earlier in May, entered into an exclusive license agreement with NiKang Therapeutics and obtained an exclusive license to develop and commercialize NKT2152 for the treatment of cancer within China.
- Hansoh’s self-developed oncology drug is getting closer to the UK approval through its partner EQRx. The company received approval for one generic oncology drug in China.
Wuxi Biologics (2269.HK) 2022H1 – Hard to Achieve V-Share Rebound
- WuXi Biologics released 2022H1 results. The Company maintained its growth momentum. We highlight some positive sides. However, gross profit margin decreased. Considering the future trend, margin performance is not optimistic.
- A drop in demand has already occurred. Meanwhile, after the biologic drug boom has passed, the “low-hanging fruit” is gone, there could be more magnified cyclical problems for WuXi Biologics.
- As an old generation CXO, it’s difficult for WuXi Biologics to achieve V-shaped rebound or hit new highs.2022 is a good time to offload. Investors can take advantage of it.
ENN Energy (2688 HK): Seeing Sign of an Upturn
- Core net profit rose a healthy 10.9% at ENN Energy (2688 HK) in 1H22 despite challenges from pandemic lockdowns and surge in input costs.
- We expect to see sequential improvement in both dollar margin for gas sales and overall gross margin in 2H22. Excellent integrated energy pipeline should add to earnings momentum.
- Gearing improved 2.2pp in 1H22 and there is more room to deleverage in 2H22. While the stock’s valuation is not particularly cheap, it has probably already hit the trough.
China Internet Weekly (22Aug22): E-Commerce, Logistics, Online Game, Food Delivery
- Logistics companies’ revenue grew by over 10%, which reflects the recovery of e-commerce.
- The market size of Chinese online game continued to shrink in July.
- Alibaba’s Ele.me sets up a mini-program on TikTok to fight Meituan.
Morning Views Asia: CIFI Holdings, Kawasan Industri Jababeka, Sino-Ocean Service, Times China
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars